| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 王道 | 申万宏源 | 医药生物 | 38.45% | 38.55% | 40.35% | 33.33% | 4 | -42.73% | 2025-08-11 |
| 2 | 仰佳佳 | 申万宏源 | 医药生物 | 38.43% | 41.07% | 31.62% | 23.08% | 1 | -37.64% | 2025-06-10 |
| 3 | 张林晚 | 上海证券 | 医药生物 | 38.42% | 43.65% | 33.68% | -100.00% | 1 | -18.93% | 2025-07-15 |
| 4 | 王班 | 民生证券 | 医药生物 | 38.36% | 40.07% | 29.22% | -21.43% | 15 | -61.25% | 2025-08-05 |
| 5 | 阳景 | 浦银国际证券 | 医药生物 | 38.32% | 33.35% | 18.77% | 100.00% | 4 | 0.00% | 2025-06-12 |
| 6 | 王道 | 申万宏源 | 医药生物 | 38.29% | 39.85% | 43.33% | 33.33% | 4 | -42.73% | 2025-07-25 |
| 7 | 仰佳佳 | 申万宏源 | 医药生物 | 38.25% | 43.26% | 11.15% | 23.08% | 1 | -37.64% | 2025-07-18 |
| 8 | 胡博新 | 华鑫证券 | 医药生物 | 38.23% | 42.75% | 39.16% | -6.32% | 3 | -51.98% | 2025-07-25 |
| 9 | 韩世通 | 中信证券 | 医药生物 | 38.18% | 39.65% | 28.38% | -2.04% | 6 | -63.25% | 2025-07-22 |
| 10 | 马云涛 | 国元证券 | 医药生物 | 38.17% | 39.08% | 17.67% | -17.65% | 1 | -47.07% | 2025-08-11 |
| 11 | 王班 | 民生证券 | 医药生物 | 38.12% | 41.43% | 28.50% | -21.43% | 15 | -61.25% | 2025-07-28 |
| 12 | 周豫 | 太平洋 | 医药生物 | 38.11% | 44.38% | 31.69% | 21.21% | 23 | -55.62% | 2025-07-17 |
| 13 | 仰佳佳 | 申万宏源 | 医药生物 | 38.08% | 38.10% | -0.61% | 23.08% | 1 | -37.64% | 2025-08-05 |
| 14 | 叶思奥 | 光大证券 | 医药生物 | 38.02% | 39.78% | 46.17% | -25.00% | 3 | -47.18% | 2025-08-05 |
| 15 | 刘浩 | 华创证券 | 医药生物 | 38.02% | 33.30% | 41.28% | 29.41% | 1 | -47.33% | 2025-04-09 |
| 16 | 刘浩 | 华创证券 | 医药生物 | 38.01% | 29.50% | 26.28% | 29.41% | 2 | -47.33% | 2025-05-21 |
| 17 | 王道 | 申万宏源 | 医药生物 | 37.90% | 37.32% | 40.40% | 33.33% | 4 | -42.73% | 2025-08-07 |
| 18 | 马云涛 | 国元证券 | 医药生物 | 37.76% | 38.69% | 16.88% | -17.65% | 1 | -47.07% | 2025-08-12 |
| 19 | 仰佳佳 | 申万宏源 | 医药生物 | 37.76% | 42.52% | 35.45% | 23.08% | 1 | -37.64% | 2025-05-06 |
| 20 | 杨松 | 天风证券 | 医药生物 | 37.73% | 37.97% | 26.80% | -40.89% | 19 | -72.65% | 2025-08-07 |